Back to dashboard
CommercialCoverageMedium impact

08.02.26, Nogapendekin alfa inbakicept-pmln (Anktiva®)

Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Apr 21, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

A new commercial policy for Nogapendekin alfa inbakicept-pmln (Anktiva®) has been established, creating coverage guidelines for this newly approved medication. This pharmacy policy will define coverage criteria, prior authorization requirements, and billing procedures for this drug when the policy takes effect.

Action Required

Action needed
Before April 21, 2025: Billing team must review the full policy details at the source URL to understand coverage criteria, prior authorization requirements, and proper billing procedures for Nogapendekin alfa inbakicept-pmln (Anktiva®). Update billing system with any new requirements once full policy details are available.

Related policy hubs